Upcoming online seminar:
Therapeutic Drug Monitoring (TDM) | 30th of September, 2020
We have the pleasure to invite you to our upcoming online seminar on Therapeutic Drug Monitoring (TDM) which will take place the 30th of September at 4 pm CET. „Anti-drug antibodies – what should we do with this?“
When we are doing therapeutic drug monitoring of biologics proactively or reactively, drug concentrations may be low or undetectable and we will want to test for antibodies against the drug.
In case we then find antibodies against the drug, what should we do?
Your referent:
Dr. Niels Vande Casteele,
Assistant Professor of Medicine at University of California in San Diego
During this upcoming online seminar, Dr. Niels Vande Casteele will address this question by covering the following learning objectives:
- Understand the factors contributing to immunogenicity
- Understand how to measure immunogenicity
- Describe the impact of immunogenicity on pharmacokinetics
- Describe the impact of immunogenicity on efficacy and safety
- Evaluate strategies to overcome/prevent immunogenicity
This online seminar is open for everybody interested in therapeutic drug monitorings, clinicians like rheumatologists and gastroenterologists, lab staff (lab doctors and lab technicicans) and pharmacology staff (pharmacologists, lab technicians and pharma industry). Language is English.
At the end of the presentation from Dr. Niels Vande Casteele there is a possibility to ask questions, in case you have questions later, you are always welcome to mail questions to csi@r-biopharm.de .
We will forward the questions to Dr. Niels Vande Casteele.
apDia bvba and R-Biopharm AG are licensed by the KU Leuven to commercialize their monoclonal antibodies.